CLINICAL_TRIALS
trial_result
· 2012-09-03
Clinical Trial Update: Safety Study to Evaluate FluMist in Immunocompromised Children [Phase 1]
Summary
A Phase 1 safety study assessing FluMist in immunocompromised children with cancer; completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MedImmune LLC | Conditions: Cancer | Phase 1 | Status: COMPLETED | Results posted: 2012-09-03